Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area

PURPOSE: Lactate dehydrogenase (LDH), which was an indirect marker of hypoxia, was a potentially prognostic factor in several malignancies. There is a lack of evidence about the prognostic value of serum LDH level in patients with hepatocellular carcinoma (HCC) receiving sorafenib treatment from hep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Li, Mu-xing, Zhao, Hong, Bi, Xin-yu, Li, Zhi-yu, Yao, Xue-song, Li, Huai, Huang, Zhen, Han, Yue, Zhou, Jian-guo, Zhao, Jian-jun, Zhang, Ye-fan, Zhao, Dong-bin, Cai, Jian-qiang
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349941/
https://ncbi.nlm.nih.gov/pubmed/27880930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13428
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados